Health Care & Life Sciences » Biotechnology | OncoTherapy Science Inc.

OncoTherapy Science Inc. | Balance Sheet

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Cash & Short Term Investments
17,825
16,072
13,070
10,073
6,740
4,858
Total Accounts Receivable
-
34
12
-
2
17
Inventories
26
22
16
92
98
36
Other Current Assets
256
131
202
122
195
144
Total Current Assets
18,141
16,237
13,288
10,289
7,034
5,055
Net Property, Plant & Equipment
279
254
277
220
582
201
Total Investments and Advances
65
64
64
64
-
-
Intangible Assets
93
52
25
16
285
9
Other Assets
1
1
9
4
121
102
Total Assets
18,579
16,608
13,663
10,593
8,022
5,367
Income Tax Payable
38
43
32
55
5
Other Current Liabilities
548
296
339
315
301
Total Current Liabilities
587
338
371
370
306
Provision for Risks & Charges
83
85
86
107
123
Deferred Taxes
19
14
11
11
13
Other Liabilities
108
108
80
-
-
Total Liabilities
796
545
549
488
442
Common Equity (Total)
17,640
16,064
13,115
10,104
7,323
Total Shareholders' Equity
17,640
16,064
13,115
10,104
7,323
Total Equity
17,783
16,064
13,115
10,104
7,580
Liabilities & Shareholders' Equity
18,579
16,608
13,663
10,593
8,022
Accumulated Minority Interest
143
-
-
-
257

About OncoTherapy Science

View Profile
Address
Kanagawa Science Park R&D D Bldg.
Kawasaki Kanagawa 213
Japan
Employees -
Website http://www.oncotherapy.co.jp
Updated 07/08/2019
OncoTherapy Science, Inc. engages in the research and development of pharmaceutical products. It focuses its research on cancer-related cells and genes, and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine and nucleic acid drugs. The company was founded on April 6, 2001 and is headquartered in Kawasaki, Japan.